DS-Connect®: The Down Syndrome Registry

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this study is to develop a registry for Down syndrome (DS) to facilitate research participation by individuals with Down syndrome. DS-Connect® is an online survey tool designed to collect demographic data and health information from individuals with DS. It is open to all people with Down syndrome. The purposes of DS-Connect® are: 1. To identify the various phenotypic manifestations of DS. 2. To identify individuals with DS who may be eligible for research studies or new clinical trials, based on specific information about their diagnosis and health history.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Adults (at least 18 years of age) with a diagnosis of DS (including mosaic DS or partial trisomy 21) who are capable of providing consent to participate, or for whom a legally authorized representative (LAR) may give permission on behalf of the individual to participate. Adults with DS who cannot consent for themselves but can provide assent would need to provide assent to their LAR.

• Children (up to age 18 years of age) with a diagnosis of DS. Parents/guardians may enter registry information and give permission to participate on behalf of their child; if the child is over 7 years of age and able to provide assent, they must do so. (Note: Once a child has reached age 18, he or she will be prompted to re-enroll into the registry as an adult, if he/she is able to provide informed consent or with the consent of his/her LAR if unable to re-enroll themselves.)

⁃ No individuals with DS will be excluded from taking part in DS-Connect based on age, race, ethnicity, or gender.

Locations
United States
Colorado
Linda Crnic Institute for Down Syndrome
RECRUITING
Aurora
Contact Information
Primary
Anne Fiala
info@ds-connect.org
(303) 724-6599
Backup
Angela Rachubinski, PhD
Time Frame
Start Date: 2013-09-06
Estimated Completion Date: 2035-06
Participants
Target number of participants: 100000
Treatments
Down syndrome cohort
Individuals who have a diagnosis of complete trisomy 21, translocation Down syndrome or mosaic Down syndrome.
Related Therapeutic Areas
Sponsors
Collaborators: Linda Crnic Institute for Down Syndrome, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Leads: University of Colorado, Denver

This content was sourced from clinicaltrials.gov